Showing 1971-1980 of 6064 results for "".
From Diagnosis to Prognosis: Using MyPath® Melanoma and DecisionDx®-Melanoma to Help Guide Patient Management Decisions
https://practicaldermatology.com/programs/practical-dermatology/from-diagnosis-to-prognosis-using-mypath-melanoma-and-decisiondx-melanoma-to-help-guide-patient-management-decisions/39944/Gene Expression Profile Testing Helps Clinicians Clarify Diagnostically Ambiguous Lesions and Deliver Personalized, Risk-Aligned Melanoma CareComorbidities in Vitiligo
https://practicaldermatology.com/issues/august-2025/comorbidities-in-vitiligo/36702/Vitiligo is a chronic, acquired pigmentary disorder characterized by the progressive loss of function or destruction of melanocytes in the skin, hair follicles, and mucous membranes. In this piece, Dr. Brad Glick and colleagues explore comorbidities in vitiligo.Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
https://practicaldermatology.com/programs/cme/data-driving-recent-guideline-updates-in-neoadjuvant-therapy-for-resectable-melanoma/36322/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
https://practicaldermatology.com/programs/cme/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iibiic-melanoma/36324/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
https://practicaldermatology.com/programs/cme/emerging-and-practice-changing-data-in-immunotherapy-strategies-for-melanoma/36330/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Comorbidities in Hidradenitis Suppurativa
https://practicaldermatology.com/issues/march-2025/comorbidities-in-hidradenitis-suppurativa/33164/Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease characterized by inflamed abscesses, nodules forming tunnels that can lead to scarring in intertriginous areas.On Mentorship, Open- Mindedness, and Fulfillment: A Chat with Dr. Peter Lio
https://practicaldermatology.com/youngmd-connect/wrap-ups/on-mentorship-open-mindedness-and-fulfillment-a-chat-with-dr-peter-lio/29892/Young MD Connect recently hosted a mentorship session with Dr. Peter Lio to learn from a practicing professional in the field of dermatology in a relaxed “Ask Me Anything” setting. Dr. Lio is a clinical assistant professor of dermatology and pediatrics at Northwestern University and the founding dirMonoclonal Antibodies for Restoring a Healthy Skin Microbiome in Atopic Dermatitis Patients
https://practicaldermatology.com/topics/research-update/monoclonal-antibodies-restoring-healthy-skin-microbiome-atopic-dermatitis-patients/24566/Monoclonal Antibodies for Restoring a Healthy Skin Microbiome in Atopic Dermatitis PatientsUnlocking the Potential of Regenerative Medicine in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/unlocking-the-potential-of-regenerative-medicine-in-dermatology/24022/Advances in regenerative medicine have led to a new generation of therapeutic approaches and options.Close Up With Martina M. Cartwright, PhD
https://practicaldermatology.com/topics/skin-of-color/close-up-with-martina-m-cartwright-phd/23985/